Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-192-6 | CAS number: 104-29-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.64 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 122.5 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Inhalation is not the preferred route for absorption. Original value is NOAEL 100 mg/kg bw/day, subacute toxicity in rat by oral administration. Allometric scaling from rat to human is 4. The result is multiplied by 70 kg considered as the average weight of a human being (bw) and divided by 10 m^3/person considered as the average volume that is breathed in a 8h exposure. Conclusion [(100 mg/kg bw/d / 4)*70 kg bw]/10 m^3/person= 175 mg/m^3. This value should be multiply by 0.5 (considering the oral absorption 50% in oral-to-inhalation extrapolation) and by 1.4 (considering the correction for differences between human and experimental exposure conditions, i.e. 7 days per week (experimental)/ 5 days per week (worker population)). NAEC is 122.5 mg/ m^3.
- AF for dose response relationship:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6).
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value proposed n ECHA R.8 Guidance for sub-acute to chronic (table R 8.6).
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Already considered in NOAEC calculation (Appendix R 8.2).
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6).
- AF for intraspecies differences:
- 5
- Justification:
- Default value proposed in ECHA R.8 Guidance for worker (table R 8.6).
- AF for the quality of the whole database:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6) for database of good quality and reliability.
- AF for remaining uncertainties:
- 1
- Justification:
- No further uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.467 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Modified dose descriptor starting point:
- other: NOAEL ( 100 mg/ kg bw/day) modified considering the differences between human and experimental exposure conditions.
- Value:
- 140 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Original value NOAEL 100 mg/kg bw/day (subacute toxicity in rat by oral administration) was multiplied by 1.4 (considering the correction for differences between human and experimental exposure conditions, i.e. 7 days per week (experimental)/ 5 days per week (worker population)). Starting point = 100 mg/ kg bw/day * 1.4 = 140 mg/ kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6).
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value proposed n ECHA R.8 Guidance for sub-acute to chronic (table R 8.6).
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default value proposed in ECHA R.8 guidance ( table R 8.3)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6).
- AF for intraspecies differences:
- 5
- Justification:
- Default value proposed in ECHA R.8 Guidance for worker (table R 8.6).
- AF for the quality of the whole database:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6) for database of good quality and reliability.
- AF for remaining uncertainties:
- 1
- Justification:
- No further uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
Chlorphenesin is classified H315 (skin irr. cat.2) and H319 (eye irr.cat.2) according to the CLP Regulation (EC n.1272/2008).
The assessment is done based on repeated dose toxicity studies (NOAEL 28 days rat =100 mg/kg bw/day).
The values of DNEL calculated for workers are:
INHALATION ROUTE:
SYSTEMIC EFFECTS:
a) LONG TERM: DNEL= 1.64 mg/m^3 (NAEC= 122.5 mg/m^3 and Overall AF= 75)
b) SHORT TERM: No hazard identified
LOCAL EFFECTS: Low hazard identified for LONG and SHORT TERM exposure based on its potential to be irritant for mucous membrane of nasopharyngeal region.
DERMAL ROUTE:
SYSTEMIC EFFECTS:
a) LONG TERM: DNEL = 0.467 mg/kg bw/day (Starting point: 100 mg/kg bw/day(NOAEL) *1.4 = 140 mg/kg bw/day and Overall AF= 300)
b) SHORT TERM: No hazard identified
LOCAL EFFECTS: Low hazard identified for LONG AND SHORT TERM based on the substance has been classified irritant to the skin (H315).
HAZARD FOR EYE:LOCAL EFFECTS: Low hazard identified based on the substance has been classified irritant to the eyes (H319).
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.247 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 37.5 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Inhalation is not the preferred route for absorption. Original value is NOAEL 100 mg/kg bw/day, subacute toxicity in rat by oral administration. Allometric scaling from rat to human is 4. The result is multiplied by 60 kg considered as the average weight of a human being (bw) and divided by 20m^3/person considered as the average volume that is breathed by general population . Conclusion [(100 mg/kg bw/d / 4)*60 kg bw]/20 m^3/person= 75 mg/m^3. This value should be multiply by 0.5 (considering the oral absorption 50% in oral-to-inhalation extrapolation). NAEC is 37.5 mg/ m^3.
- AF for dose response relationship:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6)
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value proposed n ECHA R.8 Guidance for sub-acute to chronic (table R 8.6)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Already considered in NOAEC calculation (Appendix R8.2)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6)
- AF for intraspecies differences:
- 10
- Justification:
- Default value proposed in ECHA R.8 Guidance for general population (table R 8.6)
- AF for the quality of the whole database:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6) for database of good quality and reliability.
- AF for remaining uncertainties:
- 1
- Justification:
- No further uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.167 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 100 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6).
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value proposed n ECHA R.8 Guidance for sub-acute to chronic (table R 8.6).
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default value proposed in ECHA R.8 guidance ( table R 8.3).
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6).
- AF for intraspecies differences:
- 10
- Justification:
- Default value proposed in ECHA R.8 Guidance for general population (table R 8.6).
- AF for the quality of the whole database:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6) for database of good quality and reliability.
- AF for remaining uncertainties:
- 1
- Justification:
- No further uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- Explanation for the modification of the dose descriptor starting point:
A DNEL is not derived as no acute toxicity hazard leading to Classification & Labelling was identified (ECHA guidance document R 8.1.2.5). According to the Commission Regulation (EU) 2016/863 of 31 May 2016 amending Annexes VII and VIII to Regulation (EC) No 1907/2006 testing by the dermal route does not need to be conducted if the substance does not meet the criteria for classification as acute toxicity or STOT SE by the oral route and no systemic effects have been observed in vivo studies with dermal exposure (e.g. skin irritation, skin sensitisation). LD 50 oral route for Chlorphenesin is major than 2000 mg/kg bw and no classification is required for acute oral toxicity.
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.167 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 100 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
No route to route extrapolation.
- AF for dose response relationship:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6).
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value proposed n ECHA R.8 Guidance for sub-acute to chronic (table R 8.6).
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default value proposed in ECHA R.8 guidance ( table R 8.3).
- AF for other interspecies differences:
- 2.5
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6).
- AF for intraspecies differences:
- 10
- Justification:
- Default value proposed in ECHA R.8 Guidance for general population (table R 8.6).
- AF for the quality of the whole database:
- 1
- Justification:
- Default value proposed in ECHA R.8 Guidance (table R 8.6) for database of good quality and reliability.
- AF for remaining uncertainties:
- 1
- Justification:
- No further uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
Chlorphenesin is classified H315 (skin irr. cat.2) and H319 (eye irr.cat.2) according to the CLP Regulation (EC n.1272/2008).
The assessment is done based on repeated dose toxicity studies (NOAEL 28 days rat =100 mg/kg bw/day).
The values of DNEL calculated for general population are:
INHALATION ROUTE:
SYSTEMIC EFFECTS:
a) LONG TERM: DNEL= 0.247 mg/m^3 (NAEC= 37.5 mg/m^3 and Overall AF= 150)
b) SHORT TERM: No hazard identified
LOCAL EFFECTS: Low hazard identified for LONG AND SHORT TERM based its potential to be irritant for mucous membrane of nasopharyngeal region
DERMAL ROUTE:
SYSTEMIC EFFECTS:
a) LONG TERM: DNEL = 0.167 mg/kg bw day (Starting point NOAEL= 100 mg/kg bw/day and Overall AF= 600)
b) SHORT TERM: No hazard identified
LOCAL EFFECTS: Low hazard identified for LONG AND SHORT TERM based on the substance has been classified irritant to the skin.
ORAL ROUTE:
SYSTEMIC EFFECTS:
a) LONG TERM: DNEL = 0.167 mg/kg bw/day (NOAEL= 100 mg/kg bw/ day and Overall AF= 600)
b) SHORT TERM: : No hazard identified based on the substance is not classified for acute oral toxicity.
HAZARD FOR EYE:LOCAL EFFECTS: Low hazard identified based on the substance has been classified irritant to the eyes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
